Department of Oncology, Lund University Hospital, Lund

Publications, 2004

1. Akervall J., Guo X., Qian C. N., Schoumans J., Leeser B., Kort E., Cole A., Resau J., Bradford C., Carey T., Wennerberg J., Anderson H., Tennvall J. and Teh B. T. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients. Clin Cancer Res 2004;10(24):8204-13.

2. Bengtsson H., Jonsson G. and Vallon-Christersson J. Calibration and assessment of channel-specific biases in microarray data with extended dynamical range. BMC Bioinformatics 2004;5(1):177.

3. Bjorck E., Ek S., Landgren O., Jerkeman M., Ehinger M., Bjorkholm M., Borrebaeck C. A., Porwit-Macdonald A. and Nordenskjold M. High expression of cyclin B1 predicts a favorable outcome of patients with follicular lymphoma. Blood 2004.

4. Brun E., Tennvall J., Baldetorp B., Kjellen E., Fallenius G. and Wennerberg J. DNA ploidy, S-phase fraction and associations with 2-18F-Fluoro-Deoxy-2D-gluose positron emission tomography findings before and during therapy of head and neck squamous cell carcinoma. Acta Otolaryngologica 2004;124:1-8.

5. Di Fiore F., Charbonnier F., Martin C., Frerot S., Olschwang S., Wang Q., Boisson C., Buisine M. P., Nilbert M., Lindblom A. and Frebourg T. Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC. J Med Genet 2004;41(1):18-20.

6. Dryver E., Brandt L., Kauppinen T. and Olsson H. Occupational exposures and non- Hodgkin's lymphoma in Southern Sweden. Int J Occup Environ Health 2004;10(1):13- 21.

7. Eberhard J., Stahl O., Giwercman Y., Cwikiel M., Cavallin-Stahl E., Lundin K. B., Flodgren P. and Giwercman A. Impact of therapy and androgen receptor polymorphism on sperm concentration in men treated for testicular germ cell cancer: a longitudinal study. Hum Reprod 2004;19(6):1418-25.

8. Eden P., Ritz C., Rose C., Ferno M. and Peterson C. "Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers. Eur J Cancer 2004;40(12):1837-41.

9. Engellau J., Anderson H., Rydholm A., Bauer H. C., Hall K. S., Gustafson P., Akerman M., Meis-Kindblom J., Alvegard T. A. and Nilbert M. Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas. Cancer 2004;100(10):2233-9.

10. Engellau J., Persson A., Bendahl P. O., Akerman M., Domanski H. A., Bjerkehagen B., Lilleng P., Weide J., Rydholm A., Alvegard T. A. and Nilbert M. Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67. Virchows Arch 2004;445(3):224-30.

1 11. Ericson K., Nilbert M., Bladstrom A., Anderson H., Olsson H. and Planck M. Familial risk of tumors associated with hereditary non-polyposis colorectal cancer: a Swedish population-based study. Scand J Gastroenterol 2004;39(12):1259-1265.

12. Ericson K., Engellau J., Persson A., Lindblom A., Domanski H., Akerman M. and Nilbert M. Immunohistochemical loss of the DNA mismatch repair proteins MSH2 and MSH6 in malignant fibrous histocytomas. Sarcoma 2004;8(4):123-127.

13. Fernebro E., Bendahl P. O., Dictor M., Persson A., Ferno M. and Nilbert M. Immunohistochemical patterns in rectal cancer: Application of tissue microarray with prognostic correlations. Int J Cancer 2004;111(6):921-8.

14. Ferreri A. J., Campo E., Ambrosetti A., Ilariucci F., Seymour J. F., Willemze R., Arrigoni G., Rossi G., Lopez-Guillermo A., Berti E., Eriksson M., Federico M., Cortelazzo S., Govi S., Frungillo N., Dell'Oro S., Lestani M., Asioli S., Pedrinis E., Ungari M., Motta T., Rossi R., Artusi T., Iuzzolino P., Zucca E., Cavalli F. and Ponzoni M. Anthracycline- based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol 2004;15(8):1215-21.

15. Gadjieva R., Axelsson E., Olsson U., Vallon-Christersson J. and Hansson M. Nonsense- mediated mRNA decay in barley mutants allows the cloning of mutated genes by a microarray approach. Plant Physiol Biochem 2004;42(7-8):681-5.

16. Giwercman A., Lundin K. B., Eberhard J., Stahl O., Cwikiel M., Cavallin-Stahl E. and Giwercman Y. L. Linkage between androgen receptor gene CAG trinucleotide repeat length and testicular germ cell cancer histological type and clinical stage. Eur J Cancer 2004;40(14):2152-8.

17. Gruvberger-Saal S. K., Eden P., Ringner M., Baldetorp B., Chebil G., Borg A., Ferno M., Peterson C. and Meltzer P. S. Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles. Mol Cancer Ther 2004;3(2):161-8.

18. Guenel P., Cyr D., Sabroe S., Lynge E., Merletti F., Ahrens W., Baumgardt-Elms C., Menegoz F., Olsson H., Paulsen S., Simonato L. and Wingren G. Alcohol drinking may increase risk of breast cancer in men: a European population-based case-control study. Cancer Causes Control 2004;15(6):571-80.

19. Hakansson P., Lassen C., Olofsson T., Baldetorp B., Karlsson A., Gullberg U. and Fioretos T. Establishment and phenotypic characterization of human U937 cells with inducible P210 BCR/ABL expression reveals upregulation of CEACAM1 (CD66a). Leukemia 2004.

20. Halvarsson B., Lindblom A., Rambech E., Lagerstedt K. and Nilbert M. Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer? Virchows Arch 2004;444(2):135-41.

21. Hansen S., Sorensen F. B., Vach W., Grabau D. A., Bak M. and Rose C. Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients. Histopathology 2004;44(5):428-36.

2 22. Hardell L., Malmqvist N., Ohlson C. G., Westberg H. and Eriksson M. Testicular cancer and occupational exposure to polyvinyl chloride plastics: a case-control study. Int J Cancer 2004;109(3):425-9.

23. Hardell L., van Bavel B., Lindstrom G., Carlberg M., Eriksson M., Dreifaldt A. C., Wijkstrom H., Starkhammar H., Hallquist A. and Kolmert T. Concentrations of polychlorinated biphenyls in blood and the risk for testical cancer. Int J Androl 2004;In press.

24. Hardell L., Hallquist A., Hansson Mild K., Carlberg M., Gertzen H., Schildt E. B. and Dahlqvist A. No association between the use of cellular or cordless telephones and salivary gland tumours. Occup Environ Med 2004;61(8):675-9.

25. Henriksson K., Olsson H. and Kristoffersson U. The need for oncogenetic counselling. Ten years' experience of a regional oncogenetic clinic. Acta Oncol 2004;43(7):637-49.

26. Hogberg T., Fredstorp-Lidebring M., Alm P., Baldetorp B., Larsson G., Ottosen C., Svanberg L. and Lindahl B. A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I-II endometrial cancer. Int J Gynecol Cancer 2004;14(3):437-50.

27. Holten-Andersen M., Christensen I. J., Nilbert M., Bendahl P. O., Nielsen H. J., Brunner N. and Fernebro E. Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival. a validation study. Eur J Cancer 2004;40(1):64-72.

28. Jerkeman M., Anderson H., Dictor M., Kvaloy S., Akerman M. and Cavallin-Stahl E. Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma-a Nordic Lymphoma Group study. Ann Hematol 2004.

29. Jerkeman M., Leppa S., Kvaloy S. and Holte H. ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma-- the Nordic Lymphoma Group experience. Eur J Haematol 2004;73(3):179-82.

30. Jernstrom H., Lubinski J., Lynch H. T., Ghadirian P., Neuhausen S., Isaacs C., Weber B. L., Horsman D., Rosen B., Foulkes W. D., Friedman E., Gershoni-Baruch R., Ainsworth P., Daly M., Garber J., Olsson H., Sun P. and Narod S. A. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2004;96(14):1094-8.

31. Jogi A., Vallon-Christersson J., Holmquist L., Axelson H., Borg A. and Pahlman S. Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior. Exp Cell Res 2004;295(2):469-87.

32. Johannsdottir H. K., Johannesdottir G., Agnarsson B. A., Eerola H., Arason A., Johannsson O. T., Heikkila P., Egilsson V., Olsson H., Borg A., Nevanlinna H. and

3 Barkardottir R. B. Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables. Anticancer Res 2004;24(5A):2681-7.

33. Lahmann P. H., Gullberg B., Olsson H., Boeing H., Berglund G. and Lissner L. Birth weight is associated with postmenopausal breast cancer risk in Swedish women. Br J Cancer 2004;91(9):1666-8.

34. Landgren O., Bjorkholm M., Konradsen H. B., Soderqvist M., Nilsson B., Gustavsson A., Axdorph U., Kalin M. and Grimfors G. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma. J Intern Med 2004;255(6):664-73.

35. Link K., Moell C., Garwicz S., Cavallin-Stahl E., Bjork J., Thilen U., Ahren B. and Erfurth E. M. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab 2004;89(10):5003-12.

36. Loman N. [BRCA1 and BRCA2 have reached the clinical medicine. The 10-year old finding of the genetic mutation makes it now possible to prevent breast cancer]. Lakartidningen 2004;101(25):2172-7.

37. Malander S., Ridderheim M., Masback A., Loman N., Kristoffersson U., Olsson H., Nilbert M. and Borg A. One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations. results of a prospective study in Southern Sweden. Eur J Cancer 2004;40(3):422-8.

38. Mattisson I., Wirfalt E., Wallstrom P., Gullberg B., Olsson H. and Berglund G. High fat and alcohol intakes are risk factors of postmenopausal breast cancer: a prospective study from the Malmo diet and cancer cohort. Int J Cancer 2004;110(4):589-97.

39. Mattisson I., Wirfalt E., Johansson U., Gullberg B., Olsson H. and Berglund G. Intakes of plant foods, fibre and fat and risk of breast cancer--a prospective study in the Malmo Diet and Cancer cohort. Br J Cancer 2004;90(1):122-7.

40. Mikkelsen T., Werner M. U., Lassen B. and Kehlet H. Pain and sensory dysfunction 6 to 12 months after inguinal herniotomy. Anesth Analg 2004;99(1):146-51.

41. Nielsen K., Ingvar C., Masback A., Westerdahl J., Borg A., Sandberg T., Jonsson N., Nagel J. and Olsson H. Melanoma and nonmelanoma skin cancer in patients with multiple tumours--evidence for new syndromes in a population-based study. Br J Dermatol 2004;150(3):531-6.

42. Nielsen K., Ingvar C., Masback A., Westerdahl J., Borg A., Sandberg T., Jonsson N., Nagel J. and Olsson H. A familial syndromic association between cutaneous malignant melanoma and neural system tumours: reply from authors. Br J Dermatol 2004;151(6):1279.

4 43. Nilbert M., Meza-Zepeda L., Francis P., Berner J., HM N., Fernebro E. and Myklebost O. Lessons from genetic profiling in soft tissue sarcomas. Acta Orthop Scand 2004;Suppl 311(75):35-50.

44. Nilbert M. and Engellau J. Experiences from tissue microarray in soft tissue sarcomas. Acta Orthop Scand Suppl 2004;75(311):29-34.

45. Nimeus E., Baldetorp B., Bendahl P. O., Rennstam K., Wennerberg J., Akervall J. and Ferno M. Amplification of the cyclin D1 gene is associated with tumour subsite, DNA non-diploidy and high S-phase fraction in squamous cell carcinoma of the head and neck. Oral Oncol 2004;40(6):624-9.

46. Obad S., Brunnstrom H., Vallon-Christersson J., Borg A., Drott K. and Gullberg U. Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U- 937 cells. Oncogene 2004.

47. Olsson H. An updated review of the epidemiology of soft tissue sarcoma. Acta Orthop Scand Suppl 2004;75(311):16-20.

48. Pedersen J. L., Lilleso J., Hammer N. A., Werner M. U., Holte K., Lacouture P. G. and Kehlet H. Bupivacaine in microcapsules prolongs analgesia after subcutaneous infiltration in humans: a dose-finding study. Anesth Analg 2004;99(3):912-8, table of contents.

49. Perkins F. M., Werner M. U., Persson F., Holte K., Jensen T. S. and Kehlet H. Development and validation of a brief, descriptive Danish pain questionnaire (BDDPQ). Acta Anaesthesiol Scand 2004;48(4):486-90.

50. Ringner M., Veerla S., Andersson S., Staaf J. and Hakkinen J. ACID: a database for microarray clone information. Bioinformatics 2004;20(14):2305-6.

51. Rose C. Letter to the editor. Eur J Cancer 2004;40(18):2859.

52. Rose C., Loman N., Killander F. and Kinhult S. Systemic therapy of metastatic breast cancer in postmenopausal patients. In: Dowsett M. and Ingel J. N., eds. Endocrine Therapy of Breast Cancer, 2004: 33-46 Chapter 3.

53. Stahl O., Eberhard J., Jepson K., Spano M., Cwikiel M., Cavallin-Stahl E. and Giwercman A. The impact of testicular carcinoma and its treatment on sperm DNA integrity. Cancer 2004;100(6):1137-44.

54. Syrjakoski K., Kuukasjarvi T., Waltering K., Haraldsson K., Auvinen A., Borg A., Kainu T., Kallioniemi O. P. and Koivisto P. A. BRCA2 mutations in 154 finnish male breast cancer patients. Neoplasia 2004;6(5):541-5.

55. Thomassen M., Kruse T. A., Olsen K. E., Borg A. and Gerdes A. M. Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation. Breast Cancer Res Treat 2004;87(3):273-276.

5 56. Wallin G., Lundell G. and Tennvall J. Anaplastic giant cell thyroid carcinoma. Scand J Surg 2004;93(4):272-7.

57. Werner M. U., Duun P. and Kehlet H. Prediction of postoperative pain by preoperative nociceptive responses to heat stimulation. Anesthesiology 2004;100(1):115-9; discussion 5A.

58. Wirfalt E., Vessby B., Mattisson I., Gullberg B., Olsson H. and Berglund G. No relations between breast cancer risk and fatty acids of erythrocyte membranes in postmenopausal women of the Malmo Diet Cancer cohort (Sweden). Eur J Clin Nutr 2004;58(5):761-70.

THESIS

58. Engellau J. Prognostic factors in soft tissue sarcoma Tissue microarray for immunostaining, the importance of whole-tumor sections and time-dependence: Lund, 2004.

59. Rennstam K. Molecular cytogenetics in sporadic breastcancer: Lund, 2004.